Evidence map›Paper›PMID 41053187›Full record

SynthesisScientific reports2025

A systematic review and meta-analysis of the global prevalence of fluoroquinolone resistant Morganella morganii clinical isolates.

Kannipa Tasanapak, Sutthirat Sitthisak, Thawatchai Kitti, Wiriya Mahikul, Siriwat Kucharoenphaibul, Jintana Wongwigkarn, Nontaphat Leerach

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kannipa TasanapakDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Sutthirat SitthisakDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Thawatchai KittiDepartment of Oriental Medicine, Chiang Rai College, Chiangrai, 57000, Thailand.
Wiriya MahikulPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, 10210, Thailand.
Siriwat KucharoenphaibulDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Jintana WongwigkarnDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, 65000, Thailand.
Nontaphat LeerachPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, 10210, Thailand. nontaphat.lee@cra.ac.th.

Funding

Chulabhorn Royal Academy PSCM2568/003
6 · The paper itself

Abstract

Morganella morganii is an opportunistic pathogen that infects a variety of tissues. The increasing resistance of M. morganii to fluoroquinolones is a global public health concern. Hence, in this systematic review and meta-analysis, we aimed to determine the prevalence of fluoroquinolone resistance in M. morganii clinical isolates. We conducted a comprehensive search of the PubMed, Embase, ScienceDirect, and Scopus databases up to July 10, 2024, to identify studies on fluoroquinolone resistance in M. morganii. Studies that encompassed clinical isolates with fluoroquinolone susceptibility data were included. The prevalence of resistance was determined using a random-effects model, and heterogeneity was assessed using I

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEnterobacteriaceae InfectionsFluoroquinolonesMorganella morganiiGlobal HealthHumansMicrobial Sensitivity TestsPrevalenceAnti-Bacterial AgentsFluoroquinolones

Identifiers

PMID41053187
PMCPMC12500859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.